Adagio Medical Holdings, Inc Common Stock

Adagio Medical Announces Positive Pivotal Results for vCLAS® Ventricular Ablation System

Adagio Medical’s ULTA Technology to Be Featured at the Heart Rhythm 2026 Conference

Adagio Medical Receives IDE Approval from the FDA to Investigate Next-Generation vCLAS® Ventricular Ablation System

Adagio Medical to Participate in the 25th Annual Needham Virtual Conference

Adagio Medical Ultralow Temperature Ablation U.S. Pivotal Study Results to be Presented in Late-Breaking Session at Heart Rhythm Society 2026